Spruce: BTD For TA-ERT For MPS IIIB Could Ignite BLA Submission With Added Bonuses (Rating Upgrade)

Spruce Biosciences received FDA Breakthrough Therapy Designation for TA-ERT in treating San Filippo Syndrome Type B [MPS IIIB ...

New calculator can help physicians better predict stroke risk in atrial fibrillation patients

Researchers at the UNC School of Medicine and the University of Vermont have developed a more precise way to assess stroke ...